Marijuana in medical use

From Human's Love
Revision as of 11:22, 14 November 2022 by Cannabis-penalties-canada-10 (talk | contribs) (Created page with "There are two FDA-approved cannabinoids currently available in the United States for refractory chemotherapy-induced nausea and vomiting: dronabinol (Marinol) and nabilone (Ce...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

There are two FDA-approved cannabinoids currently available in the United States for refractory chemotherapy-induced nausea and vomiting: dronabinol (Marinol) and nabilone (Cesamet). Nabilone is also indicated for AIDS-associated wasting and spasticity due to spinal cord injury. medical marijuana in ontario , nabiximols (Sativex), is in phase 3 clinical trials for use in multiple sclerosis and neuropathic and cancer-related pain, and is already available in Europe and Canada.5 Most research suggests a very low risk of addiction and very low toxicity of medical marijuana when taken as recommended in low therapeutic doses. There is concern about psychological dependence in heavy users and whether this constitutes marijuana abuse. Some research has suggested CBD oil might be useful in the treatment of marijuana addiction or marijuana abuse.

Retrieved from "https://humanlove.stream/index.php?title=Marijuana_in_medical_use&oldid=3067697"